BHLHB2 Overexpression Is a Positive Prognostic Factor Indicating Gemcitabine Responsiveness in Pancreatic Cancer

被引：0
|
作者：
Reiser-Erkan, C. [1 ]
Wang, W. [1 ]
Erkan, M. [1 ]
Michalski, C. W. [1 ]
Friess, Helmut [1 ]
Kleeff, J. [1 ]
机构：
[1] Tech Univ Munich, Dept Surg, Munich, Germany
来源：
PANCREAS | 2010年 / 39卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1343 / 1343
页数：1
相关论文
共 50 条
  • [21] Pretreatment CA 19-9 level as a prognostic factor in patients with advanced pancreatic cancer treated with gemcitabine
    Everardo D. Saad
    Marcel C. Machado
    Dalia Wajsbrot
    Roberto Abramoff
    Paulo M. Hoff
    Jacques Tabacof
    Artur Katz
    Sergio D. Simon
    René C. Gansl
    International Journal of Gastrointestinal Cancer, 2002, 32 : 35 - 41
  • [22] Pretreatment CA 19-9 level as a prognostic factor in patients with advanced pancreatic cancer treated with gemcitabine
    Saad, ED
    Machado, MC
    Wajsbrot, D
    Abramoff, R
    Hoff, PM
    Tabacof, J
    Katz, A
    Simon, SD
    Gansl, RC
    JOURNAL OF GASTROINTESTINAL CANCER, 2002, 32 (01) : 35 - 41
  • [23] HER-2/neu overexpression is an independent prognostic factor in colorectal cancer
    Park, Dong Il
    Kang, Mun Su
    Oh, Suk Joong
    Kim, Hong Joo
    Cho, Yong Kyun
    Sohn, Chong Il
    Jeon, Woo Kyu
    Kim, Byung Ik
    Han, Won Kon
    Kim, Hungdai
    Ryu, Seung Ho
    Sepulveda, Antonia R.
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2007, 22 (05) : 491 - 497
  • [24] Practical prognostic index for patients with metastatic pancreatic cancer treated with gemcitabine
    Sawaki, Akira
    Kanemitsu, Yukihide
    Mizuno, Nobumasa
    Takahashi, Kuniyuki
    Nakamura, Tsuneya
    Ioka, Tatsuya
    Tanaka, Sachiko
    Nakaizumi, Akihiko
    Salem, Ahmed A. S.
    Ueda, Ryuzo
    Yamao, Kenji
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2008, 23 (08) : 1292 - 1297
  • [25] Prognostic factors in gemcitabine refractory advanced pancreatic cancer patients.
    Nakachi, K
    Furuse, J
    Ishii, H
    Yoshino, M
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 368S - 368S
  • [26] Leptin Overexpression as a Poor Prognostic Factor for Colorectal Cancer
    Li, Chunxiang
    Quan, Jichuan
    Wei, Ran
    Zhao, Zhixun
    Guan, Xu
    Liu, Zheng
    Zou, Shuangmei
    Wang, Xishan
    Jiang, Zheng
    BIOMED RESEARCH INTERNATIONAL, 2020, 2020
  • [27] Polypeptide N-acetylgalactosaminyltransferase 6 expression in pancreatic cancer is an independent prognostic factor indicating better overall survival
    Li, Z.
    Yamada, S.
    Inenaga, S.
    Imamura, T.
    Wu, Y.
    Wang, K-Y
    Shimajiri, S.
    Nakano, R.
    Izumi, H.
    Kohno, K.
    Sasaguri, Y.
    BRITISH JOURNAL OF CANCER, 2011, 104 (12) : 1882 - 1889
  • [28] Polypeptide N-acetylgalactosaminyltransferase 6 expression in pancreatic cancer is an independent prognostic factor indicating better overall survival
    Z Li
    S Yamada
    S Inenaga
    T Imamura
    Y Wu
    K-Y Wang
    S Shimajiri
    R Nakano
    H Izumi
    K Kohno
    Y Sasaguri
    British Journal of Cancer, 2011, 104 : 1882 - 1889
  • [29] Overexpression of Cyclin D2 in Gemcitabine-Resistant Pancreatic Cancer and its Potential as a Therapeutic Target
    Uehara, Masahiro
    Takenaka, Satoshi
    Domoto, Takahiro
    Horike, Shinichi
    Takahashi, Chiaki
    Miyashita, Tomoharu
    Minamoto, Toshinari
    CANCER SCIENCE, 2024, 115 : 336 - 336
  • [30] Prognostic factors and prognostic index for chemonaive and gemcitabine-refractory patients with advanced pancreatic cancer
    Marechal, R.
    Demols, A.
    Gay, F.
    De Maertelaere, V.
    Arvanitaki, M.
    Hendlisz, A.
    Van Laethem, J. L.
    ONCOLOGY, 2007, 73 (1-2) : 41 - 51
12345